WHO ICTRP trial
Treatment for Amavata (Rheumatoid Arthritis) with Vaitarana Basti and Agnilepa…
CTRI/2020/03/023889 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/03/023889 |
|---|---|
| Public title | Treatment for Amavata (Rheumatoid Arthritis) with Vaitarana Basti and Agnilepa in two equal groups of population. |
| Scientific title | A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF VAITARANA BASTI AND VAITARANA BASTI WITH AGNILEPA (AMALGAMATED) IN THE MANAGEMENT OF AMAVATA W.S.R. TO RA - --- |
| Primary sponsor | Parul University |
| Secondary sponsors | Parul Intitute of Ayurveda and Reasearch |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: M058- Other rheumatoid arthritis with rheumatoid factor |
| Interventions | Intervention1: Vaitarana basti and Amalgamated form of Agnilepa: dose:325ml duration: for 8 days. route: Anal route frequency: once in day. vaitarana basti is a type of enema for 8days for one group. another is fallowed by vaitaran basti… |
| Registration date | Nov 3, 2020 |
| Target size | 70 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: